Exploratory Study of Breast Cancer With ABY025

An Exploratory Study to Evaluate the Distribution of [111In]ABY-025 Uptake for SPECT Imaging in Subjects With Metastatic Breast Cancer

The aim is to study if breast cancer metastases accumulate the newly developed HER2 binding molecule 111-In-ABY025 and if that shows whether the metastases express HER2.

Inclusion Criteria:

• female age >20 years
• one or more known metastases localizations

Exclusion Criteria:

• other critical disease than breast cancer
• age ≤ 20 years